Skip to main content
. Author manuscript; available in PMC: 2019 Mar 18.
Published in final edited form as: J Alzheimers Dis. 2019;67(1):159–167. doi: 10.3233/JAD-180599

Fig. 1.

Fig. 1.

Serum PGRN levels. A) Asymptomatic carriers of c.−8+2T>G, non-carrier and controls. B) Asymptomatic and affected family members with the c.708+6_+9del deletion, non-carrier family members and controls.